Pediatric IBD is associated with predominantly subclinical pulmonary involvement, with reduced diffusing capacity emerging as the most consistent abnormality despite preserved spirometry. Longitudinal studies are needed to clarify the clinical significance and evolution of these findings.
Moriki et al. (Sun,) studied this question.